What is Xelianz
Xeljanz (tofacitinib) is a Disease Modifying Anti-Rheumatic Drug (DMARD) that suppresses the immune system to treat moderate to severe rheumatoid arthritis.
Taking Xeljanz
Xeljanz is one of the few therapies for arthritis that is available as an oral tablet. The standard dose is either one 11 mg tablet taken once a day or a 5 mg tablet, taken twice every day.
Xeljanz is currently used to treat rheumatoid arthritis with and without the medication methotrexate. Xeljanz is also used to treat psoriatic arthritis and ulcerative colitis.